Diseases & Illness |

Diabetes News

Lilly Developing Drug For Diabetic Vision Loss

RSS News Feeds
Disease from Products
Diabetes
Stroke
 All RSS Feeds

At a glance:

Eli Lilly & Co. has a drug in development, Arxxant, that seems to slow down vision loss in diabetes. 
 
While it does not prevent the problem entirely, it appears to be useful in prolonging quality of life issues for people with the disease. 
 
Currently the only way to treat diabetic retinopathy is with laser surgery once the condition is advanced. 
 
The FDA is speeding up the review process for the drug.

Lilly diabetes drug shows promise

The Courier-Journal - 6/12/2006 5:07 AM

The latest study results suggest that Eli Lilly and Co.'s experimental drug Arxxant could help millions of diabetics worldwide avoid losing their eyesight, or having to undergo laser surgery.
 
Analysts say the drug, which is awaiting federal marketing approval, could be a blockbuster for Lilly, with sales topping $1 billion a year
 
· Read The Full Diabetes Article From The Courier-Journal -->

· Read All Diabetes News Stories -->

Comments On Diabetes News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: